INOVYTEC Revenue and Competitors
Estimated Revenue & Valuation
- INOVYTEC's estimated annual revenue is currently $10.3M per year.
- INOVYTEC's estimated revenue per employee is $251,000
Employee Data
- INOVYTEC has 41 Employees.
- INOVYTEC grew their employee count by 5% last year.
INOVYTEC's People
Name | Title | Email/Phone |
---|---|---|
1 | Purchasing & Logistics Manager | Reveal Email/Phone |
INOVYTEC Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $5M | 40 | -18% | $10M | N/A |
#2 | $24.8M | 99 | 29% | N/A | N/A |
#3 | $84.1M | 0 | N/A | $1.2M | N/A |
#4 | $35.6M | 142 | 30% | N/A | N/A |
#5 | $57.5M | 229 | 6% | N/A | N/A |
#6 | $52.7M | 168 | 25% | $129.6M | N/A |
#7 | $21.1M | 84 | -3% | N/A | N/A |
#8 | $61.2M | 244 | -13% | N/A | N/A |
#9 | $60.6M | 193 | 20% | $115.5M | N/A |
#10 | $56.2M | 179 | -3% | $122.9M | N/A |
What Is INOVYTEC?
Inovytec Medical Solutions Ltd. (“Inovytecâ€) specializes in cutting-edge technologies for medical emergencies' first-line solutions, particularly for respiratory and cardiac critical aid. Inovytec products are designed to save lives where the first few minutes are crucial and dramatically affect patient's outcome. Inovytec's vision is to provide efficient live-saving devices for use by any first-responders, Anytime. Anywhere.
keywords:N/AN/A
Total Funding
41
Number of Employees
$10.3M
Revenue (est)
5%
Employee Growth %
N/A
Valuation
N/A
Accelerator
INOVYTEC News
Solutions in Critical Care secures exclusive rights in the US to carry Inovytec's Ventway Sparrow EMS and MRI ventilators.
Inovytec, founded in 2011, is an innovative medical device company developing cutting-edge solutions in the field of respiratory and cardiac...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $7.8M | 60 | 0% | N/A |
#2 | $20.1M | 68 | -1% | N/A |
#3 | $23.1M | 84 | -1% | N/A |
#4 | $13.1M | 90 | -22% | $64.5M |
#5 | $30.9M | 156 | 53% | N/A |